Latest news with #Kabi
Rakyat Post
28-05-2025
- Entertainment
- Rakyat Post
Students Hilariously Mistake Teacher's Musical Instrument For Vape
Subscribe to our FREE Music teacher Cikgu Khairul had a hilarious moment with his class when his young students accused him of smoking vape. In the video posted on his TikTok account @khairulandryan, he was about to play the guitar when a student complained that he smokes but told them not to. Momentarily confused, he asked where's the cigarette and one of his students pointed towards the item hung around his neck. siapa ada benda ni 🤣🤣 The colourful item around his neck is a musical instrument known as the kazoo. Khairul, you, and I know that, but the students don't, which makes the interaction funnier as it goes on. Realizing why they thought the colourful instrument was a vape, he proceeded to explain to the class that the item is not what they think it is. Khairul decided to turn it into an educational moment, asking the class to guess what's the name of musical instrument. He said he would give anyone who got the right answer 2000 Robux, the virtual currency in the Roblox game worth almost RM100. This immediately got the class' attention and the students involved, with one asking for the first letter. Khairul told them the instrument started with a K and gave them a few more clues while they tried guessing. At one point, Khairul nearly gave the answer away by saying ''Zoo.'' Fortunately for him, the instrument is new to the students so they didn't catch on but came up with interesting names like Kabi, Krog, and Koko Krunch. After a few rounds of guessing, Khairul revealed the name of the instrument is Kazoo but the students kept pronouncing it as 'Kazo.' He then asked which song they wanted to hear to be played with the kazoo and a girl requested for the song Aspalela by Saiful Apek. Over in the comments, netizens also tried guessing the name of the musical instrument in hopes that they could get Robux as well. Some were also surprised that the young students know the song Aspalela which was released in 2007. Most were impressed that the students know smoking was bad and praised them for being well behaved. Mostly, they loved how Khairul created a fun and lively environment for the students to learn. Share your thoughts with us via TRP's . Get more stories like this to your inbox by signing up for our newsletter.
Yahoo
08-05-2025
- Business
- Yahoo
Fresenius SE & Co KGaA (FSNUF) Q1 2025 Earnings Call Highlights: Strong EPS Growth and ...
EPS Growth: Double-digit growth, with core EPS up 12% in Q1. Kabi EBIT Margin: Increased to 16.8%. Organic Revenue Growth: 7% for the group. EBIT Growth: 4% at constant currency. Group EBIT Margin: 11.6%. Net Debt to EBITDA: Within the target range of 2.5 to 3.0. Biopharma Organic Growth: 40% driven by Tien's success. Helios EBIT Margin: 9.8% with strong performance in Spain. Free Cash Flow: Increased by nearly 2 billion. Interest Expense Reduction: Expected reduction of approximately 20 million for the year. Full Year Guidance: Reconfirmed with 7% organic top line growth and 4% EBIT growth at constant currency. Release Date: May 07, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Fresenius SE & Co KGaA (FSNUF) reported a strong start to 2025 with double-digit EPS growth, reflecting effective capital management and portfolio optimization. The company achieved a 12% increase in core EPS in Q1, driven by growth and earnings expansion across its businesses. Kabi's EBIT margin increased to 16.8%, supported by strong performance in biopharma, nutrition, and medtech sectors. Helios delivered strong top-line growth, with Spain achieving a 13.1% EBIT margin and 23% EBIT growth at constant currency. The company successfully reduced its stake in Fresenius Medical Care, using proceeds to enhance returns and lower debt, strengthening its balance sheet. Negative Points The absence of energy relief in Germany affected Helios' EBIT margin, which was down year-on-year. Potential impacts from global trade uncertainties and tariff policies could affect future economic activity. The weakening of the US dollar against the euro could negatively impact reported revenue and EBIT if it persists. The company faces challenges in maintaining momentum amidst a dynamic macroeconomic and geopolitical environment. Kabi's Q2 performance may be impacted by the absence of the high-margin product Keto in China, affecting revenue and EBIT. Q & A Highlights Q: Can you provide an update on the progress of the biopharma business and its margin expectations? A: Michael Sen, CEO, explained that the biopharma business is progressing well and is approaching the structural EBIT margin range of 16-18%. The business is expected to reach this margin in the midterm, typically within 3 to 5 years, with a potential for earlier achievement if everything aligns well. The focus is on launching new molecules and expanding market share. Q: What are the plans for further deleveraging and balance sheet management? A: Sara Hennicken, CFO, stated that while significant progress was made last year, the pace of deleveraging will be slower in 2025. The focus remains on cash generation and improving EBITDA. The company aims to reach a leverage target of 2.5 to 3 times net debt over EBITDA.
